LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| SK-BR-3 | PD184352 | 0.0135 |
| SK-BR-3 | Pelitinib | 0.9522 |
| SK-BR-3 | PF431396 | 0.7197 |
| SK-BR-3 | PF477736 | 1.1508 |
| SK-BR-3 | PF562271 | 0.5617 |
| SK-BR-3 | PHA-665752 | 0.0616 |
| SK-BR-3 | PHA-793887 | 1.0226 |
| SK-BR-3 | PI103 | 0.7900 |
| SK-BR-3 | PIK-93 | 0.1714 |
| SK-BR-3 | PLX-4720 | 0.1311 |
| SK-BR-3 | QL-X-138 | 0.8075 |
| SK-BR-3 | QL-XII-47 | 0.9609 |
| SK-BR-3 | R406 | 0.0017 |
| SK-BR-3 | Radicicol | 0.9746 |
| SK-BR-3 | Sirolimus | 0.5914 |
| SK-BR-3 | Ruxolitinib | 0.0837 |
| SK-BR-3 | Saracatinib | 0.1104 |
| SK-BR-3 | SB590885 | 0.0014 |
| SK-BR-3 | Selumetinib | -0.0337 |
| SK-BR-3 | Sigma A6730 | 0.3587 |
| SK-BR-3 | Sorafenib | 0.0836 |
| SK-BR-3 | SU11274 | 0.0654 |
| SK-BR-3 | Fedratinib | 0.2768 |
| SK-BR-3 | TGX221 | 0.1165 |
| SK-BR-3 | Torin1 | 1.1045 |